Monoclonal antibody imaging agent developer Immunomedics of MorrisPlains, NJ, announced last week that it has sold $10 million inconvertible preferred stock to international investors. The investorscan convert the stock into shares of common stock over
Monoclonal antibody imaging agent developer Immunomedics of Morris
Plains, NJ, announced last week that it has sold $10 million in
convertible preferred stock to international investors. The investors
can convert the stock into shares of common stock over the next
two years.
MRI Study Identifies Pelvic Floor Parameters that May Lead to Postpartum Stress Urinary Incontinence
October 2nd 2023Researchers found that the combination of a retrovesicourethral angle, functional urethral length, and bladder funnel on MRI exams in primiparous women had a 94.7 percent AUC for predicting postpartum stress urinary incontinence (SUI).
CAD Versus AI: Let Me Know When the Alphabet Soup Matters in Radiology
October 2nd 2023Is the continued rise of artificial intelligence (AI) driven by legitimate “machine learning,” or do the frequently “suspicious” chest X-rays and questionable detection of subtle findings on head CTs reveal a hype-driven train of new products with an ultimately “planned obsolescence”?
2 Clarke Drive
Cranbury, NJ 08512